Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
Clinical trial NCT05255237 · COMPLETED
Trial details
- NCT number
- NCT05255237
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-25
- Primary completion
- 2024-06-28
- Enrollment
- 315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.